IP Intensive: The Business of Innovation – A Semester at AstraZeneca
As part of Osgoode’s IP Law and Technology Intensive Program, I had the amazing opportunity to serve a 10-week internship at AstraZeneca Canada under the
As part of Osgoode’s IP Law and Technology Intensive Program, I had the amazing opportunity to serve a 10-week internship at AstraZeneca Canada under the
As part of Osgoode’s Intellectual Property Law & Technology Intensive Program, I had the distinct pleasure of working with the Legal Affairs team at AstraZeneca
Last semester, as part of Osgoode’s Intellectual Property Law and Technology Intensive Program, I had the opportunity to work with in-house counsel at AstraZeneca Canada.
On March 16, 2015, Justice Barnes held that AstraZeneca’s Patent No 1,292,693 (“’693 Patent”), a formulation patent for omeprazole, was valid and infringed by Apotex
AstraZeneca has been selling Nexium in Canada for 13 years. It is prescribed to treat ulcers, gastroesophageal reflux disease (GERD) and related diseases. The active